Abrezekimab, CAS [[2043952-59-4]]

Produktübersicht

• Artikelname: Abrezekimab, CAS [[2043952-59-4]]
• Artikelnummer: TGM-T76896
• Hersteller Artikelnummer: T76896
• Alternativnummer: TGM-T76896-1MG,TGM-T76896-5MG,TGM-T76896-10MG,TGM-T76896-25MG,TGM-T76896-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: UCB4144 , VR 942

Produktbeschreibung

Abrezekimab (VR 942) is composed of CDP7766, leucine, and trehalose. Abrezekimab is a humanized antibody that targets human IL-13. Abrezekimab inhibits binding to IL-13Ralpha1 subunit. Abrezekimab can be used to study biological disorders associated with asthma and lung disease.

Produkteigenschaften

• Reinheit: 98.34%
• CAS Nummer: [2043952-59-4]
• Target-Kategorie: IL Receptor|||Interleukin